On July 1, 2019, SIX-listed Lonza Group AG announced that it has entered into a binding agreement regarding the acquisition of the sterile fill and finish facility of Novartis in Stein (Canton Aargau). The new facility will enable Lonza Pharma & Biotech to build on existing parenteral drug product development and testing capabilities and offer end-to-end services to its customers for clinical supply and launch. Lenz & Staehelin is advising Lonza in this transaction. The team includes the partners Hans-Jakob Diem and Stephan Erni (Corporate and M&A) and the associates Simone Ehrsam (Corporate and M&A), Fabiano Menghini (Real Estate) and Stephan Brandner (Tax).
Register now for your free, tailored, daily legal newsfeed service.
Questions? Please contact firstname.lastname@example.orgRegister
Lonza to acquire sterile fill and finish facility from Novartis
If you would like to learn how Lexology can drive your content marketing strategy forward, please email email@example.com.
Wal-Mart Stores Inc
"Generally, this service is wonderful. I find that the employment law newsfeeds are extremely helpful and relevant. The quality of the articles is usually quite good. The website provides an avenue for quick research regarding various employment law issues."